UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Converting a 401k to a retirement plan can be a strategic move. Learn when it's the right time to make that transition.
20,599 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
In a market full of headlines, some of the best gains come from stocks that fly under the radar. This guide shows you...
When a top executive sells a large block of shares, investors want clarity. This guide breaks down what RingCentral's...
USA Rare Earth's stock sprinted higher even as broader markets slipped. A major asset deal and clear production miles...
Midweek headlines can turn crypto markets on a dime. This piece explains the drivers behind bitcoin sinking wednesday...
Regulatory headlines have a way of rattling investors, especially in high-growth tech sectors. This article dives int...
A high-profile legal clash over concert logistics shines a light on how money moves in the music business. This artic...
Worthington Steel stock dropped today after the company reported solid revenue growth but weak earnings due to higher...
MP Materials jumped about 30% in a month, signaling growing investor interest in U.S. rare-earth supply. This article...
Get a clear, real-world view of Ligand (LGND) 2026 earnings. This guide breaks down revenue sources, milestones, and ...
Intuit stock has faced a tough spell, but the business remains resilient. This guide breaks down why intuit stock ove...
AMD has delivered a dramatic rally this year, but the big question remains: is the move sustainable? This article bre...